Accredited Investors Inc. Gilead Sciences, Inc. Transaction History

Accredited Investors Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	SELL	$60.0 - $68.46 $231,480 - $264,118	-3,858 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $2,322 - $2,646	-41 Reduced 1.05%	3,858 $225,000
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $496 - $624	-8 Reduced 0.2%	3,899 $246,000
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $282,632 - $328,188	3,907 New	3,907 $301,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

Stay updated on Accredited Investors Inc. with notifications on news.